Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study - PubMed (original) (raw)

Multicenter Study

. 2010 Sep;95(9):4314-23.

doi: 10.1210/jc.2009-2635. Epub 2010 Jun 16.

Affiliations

Multicenter Study

Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study

Jane A Cauley et al. J Clin Endocrinol Metab. 2010 Sep.

Abstract

Context: There is limited information on the association between sex hormones and bone loss in older men.

Objective: Our objective was to determine the longitudinal association between sex steroid hormones and bone mineral density (BMD).

Design and setting: We conducted a prospective study of 5995 men aged at least 65 yr old at six U.S. clinical centers.

Participants: Sex steroid hormones were measured in a random sample of 1602 men. After exclusions, 1238 men were included in cross-sectional analyses and 969 in longitudinal analyses. Baseline sex hormones were measured using liquid chromatography-mass spectrometry. Bioavailable (Bio) estradiol (BioE2) and testosterone (BioT) were calculated from mass action equations. SHBG was measured using chemiluminescent substrate.

Main outcome measures: BMD of the total hip, measured at baseline and once or twice afterward over 4.6 yr of follow-up, was evaluated.

Results: The annualized percent change in hip BMD increased with decreasing BioE2 (P trend = 0.03). Men with the lowest BioE2 (<39.7 pmol/liter) compared with the highest BioE2 (> or =66.0 pmol/liter) experienced 38% faster rate of BMD loss (P < 0.05). There was no association between BioT and hip BMD loss. Men with lowest BioE2, lowest BioT, and highest SHBG experienced a 3-fold faster rate of BMD loss compared with men with higher levels (P = 0.02). A threshold effect of SHBG was observed; the rate of hip BMD loss increased in men with SHBG of 49-60 nM.

Conclusions: Low BioE2 and high SHBG levels were associated with lower BMD and faster hip BMD loss. The combination of low BioE2, low BioT, and high SHBG was associated with significantly faster rates of BMD loss.

PubMed Disclaimer

Figures

Figure 1

Figure 1

A, Change in total hip BMD by quintile of baseline bioavailable estradiol. Results have been adjusted for age, race, clinic, baseline weight, and weight change (P trend = 0.03). B, Change in total hip BMD by quintile of baseline bioavailable testosterone. Results have been adjusted for age, race, clinic, baseline weight, and weight change (P trend = 0.17). C, Change in total hip BMD by quintile of baseline SHBG. Results have been adjusted for age, race, clinic, baseline weight, and weight change.

Figure 2

Figure 2

Spline fit of change in total hip BMD vs. baseline SHBG. Results have been adjusted for age, race, clinic, baseline weight, and weight change.

Figure 3

Figure 3

Combined effect of BioE2, BioT, and SHBG on total hip BMD loss. Results have been adjusted for age, race, clinic, baseline weight, and weight change. *, P < 0.05 vs. the referent group (high BioE2, high BioT, and low SHBG). The number of men in each category is as follows: 1) low BioE2, low BioT, high SHBG, n = 15; 2) low BioE2, low BioT, low SHBG, n = 43; 3) low BioE2, high BioT, high SHBG, n = 24; 4) low BioE2, high BioT, low SHBG, n = 95; 5) high BioE2, low BioT, high SHBG, n = 9; 6) high BioE2, low BioT, low SHBG, n = 107; 7) high BioE2, high BioT, high SHBG, n = 131; and 8) high BioE2, High BioT, low SHBG, n = 545.

Similar articles

Cited by

References

    1. Khosla S, Melton 3rd LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266–2274 - PubMed
    1. Center JR, Nguyen TV, Sambrook PN, Eisman JA 1999 Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84:3626–3635 - PubMed
    1. Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD 2001 Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86:3162–3165 - PubMed
    1. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW 2000 Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85:3276–3282 - PubMed
    1. Ravaglia G, Forti P, Maioli F, Nesi B, Pratelli L, Cucinotta D, Bastagli L, Cavalli G 2000 Body composition, sex steroids, IGF-1, and bone mineral status in aging men. J Gerontol A Biol Sci Med Sci 55:M516–M521 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources